Foreign Corrupt Practices Act: Device Industry Under Scrutiny
This article was originally published in The Gray Sheet
Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations
You may also be interested in...
Revisions to DoJ guidelines will let companies off the hook for self-reported overseas bribery charges in many cases. But whether or not to come forward remains a tricky decision.
Translating The Foreign Corrupt Practices Act Into Practice: DOJ/SEC Offer Pragmatic Enforcement Guide
The FCPA resource guide gives examples of cases the DOJ and SEC have decided not to prosecute and describes the hallmarks of an effective compliance program. AdvaMed was among groups that asked for more clarity.
Syneron buys UltraShape. Smith & Nephew settles foreign bribery charges. Hospitals settle kyphoplasty allegations. More news briefs.